Artificial Intelligence in Genomics Market Latest Trends and Future Opportunities Analysis to 2030

InsightAce Analytic Pvt. Ltd. is pleased to announce the publication of a market analysis research on the "global artificial intelligence in genomics market trends, industry competition analysis, revenue and forecast to 2030."

Request for Sample Pages:
Artificial intelligence plays a vital role in genomics to develop and innovate effective drugs and treatments for curing various diseases. It also enhances the interpretability of genomic data and improves the efficacy of the overall analysis and development process.

The high prevalence of chronic & genetic diseases, growing R&D activities for the development of AI technologies, increasing use of AI and machine learning applications in genomics, rising adoption of AI in pharmaceutical companies for drug development and research activities, increased demand for personalized medicine, rising awareness among researchers regarding the AI applications and tools, and the need to analyze the patients' data using AI to innovate effective treatments are expected to drive the market growth significantly in the coming years. The growing patient pool increases the volume of healthcare data, making dataset handling and analysis difficult. This increased data thereby fuels the demand for AI in genomics.

Get Free Sample Copy of Report :
https://www.insightaceanalytic.com/request-sample/1122

However, the limited knowledge of AI applications and lack of a skilled AI workforce is expected to hinder the market adoption during the forecast period.

Geographically, North America region accounted for the highest share of the market in 2020, followed by Europe owing to the increasing R&D initiatives for promoting precision medicine.

Request for ToC/Proposal:
Major market players operating in the artificial intelligence in genomics market include AI Therapeutics (US), Inc., Ares Genetics GmbH (Austria), BenevolentAI (UK), BioSymetrics (US), Cambridge Cancer Genomics (UK), Clover Therapeutics (US), Congenica Ltd (UK), CureMatch, Inc. (the US), Cyclica Inc. (Canada), Data4Cure, Inc. (the US), Deep Genomics (Canada), Desktop Genetics Ltd. (UK), Diploid (Belgium), DNAnexus (US), FDNA Inc. (US), Freenome Holdings, Inc. (the US), Genoox, Ltd. (US), IBM (US), MolecularMatch Inc. (US), NVIDIA Corporation (US) among others.

Some of the key developments in the market are as follows:
In September 2021, Deep Genomics (Canada), a leading AI therapeutics company, collaborated with Mila, the Quebec Artificial Intelligence Institute. This collaboration allows the company to take advantage of the recruitment activities offered by Mila research institute. Deep Genomics uses AI and machine learning to program and prioritize transformational therapeutics for genetic diseases.
In December 2018, BioSymetrics, Inc. (US), a company engaged in computational biology, launched Augusta, a pre-processing and analytics platform. Augusta is a proprietary technology that facilitates the rapid deployment of AI projects in precision medicine, drug discovery, and health data applications.

Curious about this latest version of the report? Obtain Report Details @
https://www.insightaceanalytic.com/report/global-artificial-intelligence-in-genomics-market/1122

Market Segments
Global Artificial Intelligence in Genomics Market, by Offering, 2020-2030 (Value US$ Mn)
Software
Services

Global Artificial Intelligence in Genomics Market, by Applications, 2020-2030 (Value US$ Mn)
Diagnostics
Drug Discovery & Development
Precision Medicine
Agriculture & Animal Research
Other Applications

Global Artificial Intelligence in Genomics Market, by Technology, 2020-2030 (Value US$ Mn)
Machine Learning
Deep Learning
Supervised Learning
Reinforcement Learning
Unsupervised Learning
Other Machine Learning Technologies
Other Technologies

Global Artificial Intelligence in Genomics Market, by Functionality, 2020-2030 (Value US$ Mn)
Genome Sequencing
Gene Editing
Clinical Workflows
Predictive Genetic Testing & Preventive Medicine

Global Artificial Intelligence in Genomics Market, by End-Users, 2020-2030 (Value US$ Mn)
Pharmaceutical & Biotech Companies
Healthcare Providers
Research Centers, Academic Institutes & Government Organizations
Other End-Users

Global Artificial Intelligence in Genomics Market, by Region, 2020-2030 (Value US$ Mn)
North America
Europe
Asia Pacific
Latin America
Middle East & Africa

North America Artificial Intelligence in Genomics Market, by Country, 2020-2030 (Value US$ Mn)
The U.S.
Canada

Europe Artificial Intelligence in Genomics Market, by Country, 2020-2030 (Value US$ Mn)
Germany
France
Italy
Spain
Russia
Rest of Europe

Asia Pacific Artificial Intelligence in Genomics Market, by Country, 2020-2030 (Value US$ Mn)
India
China
Japan
South Korea
Australia & New Zealand

Latin America Artificial Intelligence in Genomics Market, by Country, 2020-2030 (Value US$ Mn)
Brazil
Mexico
Rest of Latin America

Middle East & Africa Artificial Intelligence in Genomics Market, by Country, 2020-2030 (Value US$ Mn)
GCC Countries
South Africa
Rest of Middle East & Africa

Why should buy this report:
To receive a comprehensive analysis of the prospects for global artificial intelligence in the genomics market
To receive an industry overview and future trends in artificial intelligence in the genomics market
To analyze the artificial intelligence in genomics market drivers and challenges
To get information on the artificial intelligence in genomics market value (US$ Mn) and forecast to 2030
Significant investments, mergers & acquisitions in the artificial intelligence in genomics market industry

For More Information @
https://www.insightaceanalytic.com/report/global-artificial-intelligence-in-genomics-market/1122

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

Corporate Office :
Office No.3050, 3rd Floor Marvel Fuego, Magarpatta Rd, Hadapsar, Pune, Maharashtra 411028

Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
info@insightaceanalytic.com

info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118

This release was published on openPR.